CASI · Categories · Form 4

CASI - SEC Form 4 insider transactions

CASI Pharmaceuticals Inc. (CASI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CASI

• 1368d
  SEC Form 4 filed by Zukiwski Alexander A

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1369d
  SEC Form 4: Huang James bought $229,662 worth of shares (55,573 units at $4.13)

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1375d
  SEC Form 4: Huang James bought $139,036 worth of shares (37,196 units at $3.74)

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1382d
  SEC Form 4: Huang James bought $166,930 worth of shares (44,527 units at $3.75)

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1385d
  SEC Form 4: Huang James bought $779,477 worth of shares (234,221 units at $3.33)

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1452d
  SEC Form 4: He Wei-Wu bought $272,506 worth of shares (88,154 units at $3.09), increasing direct ownership by 16% to 644,553 units

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1474d
  SEC Form 4 filed by Zhou Quan

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1474d
  SEC Form 4 filed by Huang James

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1474d
  SEC Form 4 filed by Wu Yue Alexander

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1474d
  SEC Form 4 filed by Shrotriya Rajesh C Md

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1645d
  SEC Form 4 filed by Zukiwski Alexander A

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1662d
  SEC Form 4: He Wei-Wu bought $394,000 worth of shares (400,000 units at $0.98), increasing direct ownership by 8% to 5,558,472 units

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1753d
  SEC Form 4: He Wei-Wu bought $613,800 worth of Common Stock (480,000 units at $1.28), increasing direct ownership by 10% to 5,163,994 units

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1778d
  SEC Form 4 filed by Zhang Larry

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1818d
  SEC Form 4 filed by Wu Yue Alexander

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1818d
  SEC Form 4 filed by Zhou Quan

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1818d
  SEC Form 4 filed by SHROTRIYA RAJESH C MD

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1818d
  SEC Form 4 filed by Huang James

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1818d
  SEC Form 4 filed by Salisbury Franklin Cary jr

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1818d
  SEC Form 4 filed by He Wei-Wu

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)
• 1896d
  SEC Form 4: Wei-Wu He bought $6,150,000 worth of Common Stock (3,000,000 units at $2.05)

  4 - CASI Pharmaceuticals, Inc. (0000895051) (Issuer)

Other CASI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends